S. Lindstedt

发表

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase

S. Lindstedt, E. Holme, E. Lock, 1992, The Lancet.

Clinical heterogeneity and molecular findings in five Polish patients with glycerol kinase deficiency: investigation of two splice site mutations with computerized splice junction analysis and Xp21 gene-specific mRNA analysis.

S. Lindstedt, M. Adamowicz, E. Pronicka, 2003, Molecular genetics and metabolism.

Vitamin B6 Metabolism in Pyridoxine Dependency with Seizures

S. Lindstedt, B. Persson, R. Zetterström, 1967 .

Transient reduction of human left ventricular mass in carnitine depletion induced by antibiotics containing pivalic acid.

S. Lindstedt, E. Holme, M. Mellander, 1995, British heart journal.

ENZYMATIC STUDIES IN A CASE OF HEREDITARY TYROSINEMIA WITH HEPATOMA

S. Lindstedt, R. Zetterström, B. Lindblad, 1969, Acta paediatrica Scandinavica.

Hereditary defect in carnitine membrane transport is expressed in skin fibroblasts

S. Lindstedt, B. Eriksson, I. Nordin, 1988, European Journal of Pediatrics.

The effect of D,L-carnitine supplementation on muscle metabolism, neuropathy, cardiac and hepatic function in hemodialysis patients. A pilot study.

S. Lindstedt, P. Nilsson-ehle, H. Thysell, 2009, Acta medica Scandinavica.

Dietary treatment in tyrosinemia (tyrosinosis). With a note on the possible recognition of the carrier state.

S. Lindstedt, W. Shasteen, R. Zetterstrom, 1967, American journal of diseases of children.

CARNITINE DEFICIENCY INDUCED BY PIVAMPICILLIN AND PIVMECILLINAM THERAPY

S. Lindstedt, E. Holme, U. Jodal, 1989, The Lancet.

The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane.

S. Lindstedt, B. Nilsson, A. Khorram-Manesh, 2010, Endocrine-related cancer.

Cytotoxic treatment of adrenocortical carcinoma

S. Lindstedt, A. Khorram-Manesh, O. Nilsson, 2001, World Journal of Surgery.

Apparatus measuring oxygen consumption and expired CO2 and 14CO2 in small subjects.

S. Lindstedt, B. Persson, J. Hakkarainen, 1970, Journal of applied physiology.

HEREDITARY TYROSINEMIA

S. Lindstedt, R. Zetterström, G. Bodegård, 1969, Acta paediatrica Scandinavica.

POSSIBILITIES FOR TREATMENT AND FOR EARLY PRENATAL DIAGNOSIS OF HEREDITARY TYROSINAEMIA

S. Lindstedt, E. Holme, B. Lindblad, 1985, The Lancet.

Diagnosis and management of tyrosinemia type I

S. Lindstedt, E. Holme, Elisabeth Holme, 1995, Current opinion in pediatrics.

Thallium poisoning--toxin elimination and therapy in three cases.

S. Lindstedt, J. Ahlmén, I. Wickström, 1983, Journal of toxicology. Clinical toxicology.

Biotin-responsive 3-methylcrotonylglycinuria with biotinidase deficiency

S. Lindstedt, E. Holme, M. Koivikko, 1985, Journal of Inherited Metabolic Disease.

Effect of short-term treatment with pivalic acid containing antibiotics on serum carnitine concentration--a risk irrespective of age.

S. Lindstedt, E. Holme, U. Jodal, 1995, Biochemical and molecular medicine.

Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione)

S. Lindstedt, E. Holme, 1998, Journal of Inherited Metabolic Disease.

Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I

S. Lindstedt, M. Grompe, J. Papaconstantinou, 1995, Nature Genetics.

Excretion of δ-aminolevulinic acid in hereditary tyrosinemia

S. Lindstedt, R. Zetterström, S. Johansson, 1969 .

Glycerol kinase deficiency: follow‐up during 20 years, genetics, biochemistry and prognosis

S. Lindstedt, G. Samuelson, A. Erikson, 2004, Acta paediatrica.

Transport of carnitine into cells in hereditary carnitine deficiency

S. Lindstedt, B. Eriksson, I. Nordin, 1989, Journal of Inherited Metabolic Disease.

Impaired ketogenesis in carnitine depletion caused by short-term administration of pivalic acid prodrug.

S. Lindstedt, E. Holme, B. Eriksson, 1994, Biochemical medicine and metabolic biology.

Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase.

S. Lindstedt, E. Holme, P. Clayton, 1993, Journal of neurology, neurosurgery, and psychiatry.

Adrenocortical Carcinoma: Surgery and Mitotane for Treatment and Steroid Profiles for Follow-up

S. Lindstedt, A. Khorram-Manesh, O. Nilsson, 1998, World Journal of Surgery.

Nontransplant treatment of tyrosinemia.

S. Lindstedt, E. Holme, 2000, Clinics in liver disease.

Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC)

S. Lindstedt, E. Holme, E. Pronicka, 1996, Journal of Inherited Metabolic Disease.

Studies on the metabolism of the phenolic acids in hereditary tyrosinemia by a gas-liquid chromatographic method.

S. Lindstedt, R. Zetterström, B. Lindblad, 1969, The Journal of laboratory and clinical medicine.

Pivalic acid-induced carnitine deficiency and physical exercise in humans.

S. Lindstedt, E. Holme, B. Eriksson, 1996, Metabolism: clinical and experimental.

Mitochondrial ATP-Synthase Deficiency in a Child with 3-Methylglutaconic Aciduria

S. Lindstedt, E. Holme, N. Larsson, 1992, Pediatric Research.

Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec.

John J. Mitchell, S. Lindstedt, E. Holme, 2012, Molecular genetics and metabolism.

Hydroxylation of aspartic acid in domains homologous to the epidermal growth factor precursor is catalyzed by a 2-oxoglutarate-dependent dioxygenase.

L. H. Huang, S. Lindstedt, E. Holme, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Cardiac effects of carnitine deficiency induced by antibiotics containing pivalic acid in children

S. Lindstedt, E. Holme, M. Mellander, 1997, Cardiology in the Young.

Exertion of delta-aminolevulinic acid in hereditary tyrosinemia.

S. Lindstedt, R. Zetterström, S. Johansson, 1969, Clinica chimica acta; international journal of clinical chemistry.

Neonatal screen for hereditary tyrosinaemia type I

S. Lindstedt, E. Holme, 1992, The Lancet.

Acute Liver Failure in a Child With Epstein-Barr Virus Infection and Undiagnosed Glycerol Kinase Deficiency, Mimicking Hemophagocytic Lymphohistiocytosis

S. Lindstedt, A. Nordenström, A. Németh, 2008, Journal of pediatric gastroenterology and nutrition.

Treatment of hereditary tyrosinaemia (fumarylacetoacetase deficiency) by enzyme substitution

S. Lindstedt, E. Holme, J. Greter, 1986, Journal of Inherited Metabolic Disease.

Studies on the partial reaction of thymine 7-hydroxylase in the presence of 5-fluorouracil.

S. Lindstedt, E. Holme, 1982, Biochimica et Biophysica Acta.

Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters.

S. Lindstedt, S. Lindstedt, A. Lindahl, 1995, Neuroendocrinology.